- Home
- HALO vs RLI Comparison
HALO vs RLI Comparison
Compare HALO & RLI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HALO
- RLI
- Stock Information
- Founded
- HALO 1998
- RLI 1965
- Country
- HALO United States
- RLI United States
- Employees
- HALO N/A
- RLI N/A
- Industry
- HALO Biotechnology: Biological Products (No Diagnostic Substances)
- RLI Property-Casualty Insurers
- Sector
- HALO Health Care
- RLI Finance
- Exchange
- HALO Nasdaq
- RLI Nasdaq
- Market Cap
- HALO 7.4B
- RLI 7.1B
- IPO Year
- HALO N/A
- RLI 1985
- Fundamental
- Price
- HALO $65.87
- RLI $74.72
- Analyst Decision
- HALO Buy
- RLI Hold
- Analyst Count
- HALO 9
- RLI 8
- Target Price
- HALO $63.78
- RLI $78.60
- AVG Volume (30 Days)
- HALO 2.0M
- RLI 411.4K
- Earning Date
- HALO 05-06-2025
- RLI 04-23-2025
- Dividend Yield
- HALO N/A
- RLI 6.73%
- EPS Growth
- HALO 55.40
- RLI N/A
- EPS
- HALO 3.76
- RLI 3.03
- Revenue
- HALO $1,084,306,000.00
- RLI $1,733,218,000.00
- Revenue This Year
- HALO $20.06
- RLI N/A
- Revenue Next Year
- HALO $24.20
- RLI $4.70
- P/E Ratio
- HALO $17.52
- RLI $24.62
- Revenue Growth
- HALO 25.64
- RLI 8.88
- 52 Week Low
- HALO $41.28
- RLI $68.50
- 52 Week High
- HALO $70.51
- RLI $91.15
- Technical
- Relative Strength Index (RSI)
- HALO 58.99
- RLI 44.77
- Support Level
- HALO $58.38
- RLI $73.82
- Resistance Level
- HALO $70.51
- RLI $75.08
- Average True Range (ATR)
- HALO 2.50
- RLI 1.67
- MACD
- HALO 0.88
- RLI -0.07
- Stochastic Oscillator
- HALO 64.61
- RLI 32.62
About HALO Halozyme Therapeutics Inc.
Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.
About RLI RLI Corp. (DE)
RLI Corp underwrites property and casualty insurance through its subsidiaries. The company offers insurance coverage in the specialty admitted market, where the products are designed for special risks. It also offers products in the excess and surplus markets, which provides an alternative for customers with risks or loss exposures that generally cannot be written in the standard admitted market. RLI distributes property and casualty insurance through its wholly-owned branch offices that market to wholesale and retail producers. The company's insurance operation segments include Casualty, Property, and Surety and it derives a majority of its revenue from the Casualty segment.